Abstract
West Nile virus (WNV) (Flaviviridae: Flavivirus) is transmitted from mosquitoes to birds, but can cause fatal encephalitis in infected humans. Since its introduction into North America in New York in 1999, it has spread throughout the western hemisphere. Multiple outbreaks have also occurred in Europe over the last 20 years. This review highlights recent efforts to understand how host pressures impact viral population genetics, genotypic and phenotypic changes which have occurred in the WNV genome as it adapts to this novel environment, and molecular epidemiology of WNV worldwide. Future research directions are also discussed.
Keywords: West Nile virus, Molecular epidemiology, Population genetics, Pathogenesis Fitness
1. Introduction
West Nile virus (WNV, Flaviviridae: Flavivirus) has emerged in recent decades as a significant burden to public health in Europe and the Americas. This emergence, in particular the recent invasion of WNV into North America in 1999 and its subsequent spread throughout the new world, has stimulated intense interest in its population genetics and evolution. The dynamics of the WNV epizootic/epidemic in N. America have been of special interest because they provide insight into a longstanding question in evolutionary and invasion biology: what happens when an exotic pathogen is introduced into a naïve environment? Both observational and laboratory studies have therefore been undertaken to determine the modes and direction of virus evolution and examine the evolutionary implications of the host–virus interactions. In this review, we highlight recent advances in research into the population and evolutionary dynamics of WNV and identify key areas for further research.
1.1. Molecular biology and replication
WNV is a member of the Japanese Encephalitis virus (JEV) serological complex of the flaviviruses (Calisher et al., 1989). The virion is enveloped, spherical (~40–60 nm in diameter) and contains a single copy of the positive-sense RNA genome (Mukhopadhyay et al., 2003; Brinton, 2009). The WNV genome is approximately 11,000 nt in length and the translated polyprotein is co- and post-translationally cleaved by viral and host-cell proteases into three structural (capsid C, premembrane prM/M, and envelope E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). C, M and E are incorporated into the mature virion, while the nonstructural proteins assemble on host cell membranes where they participate in RNA replication and suppression of the host antivirus response (Brinton, 2009, 2001; Westaway et al., 2002; Evans et al., 2011; Avirutnan et al., 2011; Ambrose and Mackenzie, 2011). Overall, the genome organization of WNV, and its protein coding strategy are similar to other flaviviruses.
WNV is believed to enter host cells by receptor-mediated endocytosis that is dependent on an Ig-like fold present in domain III of the E glycoprotein. Virus-containing vesicles enter the endocytic pathways, where acidification leads to a major reorganization of E homodimers into trimers, exposing a hydrophobic peptide (termed the cd loop) contained in the distal portion of domain II of E. Ultimately this reorganization results in fusion of the viral and host cell membranes. Identifying specific host receptors for all flaviviruses has proved difficult and the literature is currently ambiguous on which host-cell molecules are so-called attachment receptors and which, if any, are absolutely required for virus entry. Candidate receptors that have been proposed for WNV include DC-SIGN, DC-SIGNR and αvβ3 integrin (Davis et al., 2006; Chu and Ng, 2004a, b). In mosquito cells, a c-type lectin is secreted from infected cells and binds virions to enhance uptake involving a phosphatase homolog of human CD45, mosPTP-1 (Cheng et al., 2010). Once viral RNA is released into host cells, it is immediately translated by host machinery. The resulting viral nonstructural proteins assemble on host membranes and replicate the viral genome. Notably, several viral nonstructural proteins are multifunctional and the function of others are poorly defined. Excellent reviews on their roles in flavivirus replication and host cell function have been published recently (Bollati et al., 2009). Mature virions exit cells through the trans-Golgi network and are released into the extracellular milieu by exocytosis and/or budding at the plasma membrane. Thus, the life cycle of WNV within cells is similar to other RNA viruses that replicate cytoplasmically. However, WNV and other arboviruses have evolved the ability to replicate in cells of hosts that are widely taxonomically divergent (i.e. arthropods and vertebrates). This requirement for replication in different host types exerts unique evolutionary and selective pressures on the virus, which are discussed below.
1.2. Ecology
Viruses adapt to available ecological niches or they become extinct. A thorough understanding of what constitutes the “niche” for WNV is therefore critical to formulating hypotheses regarding how the virus might evolve in order to maximize its potential to perpetuate. WNV is maintained in nature in an enzootic cycle involving birds and mosquitoes. Although the specific birds and mosquitoes most important for virus perpetuation in any given focus vary locally, they tend to include birds of the order Passeriformes and mosquitoes of the genus Culex. However, nearly 60 mosquito and 300 bird species have been found infected, and the species of Culex mosquito that is most important in a given locality is highly variable. For example, in the Northeastern US, Cx. pipiens pipiens is a major vector and appears to be responsible for the vast majority of virus transmission (Bernard et al., 2001). In the central and western US, however, Cx. tarsalis is the principal vector, while in southern regions of the US, Cx. p. quinquefasciatus is most important (Bell et al., 2006; Molaei et al., 2010; Goldberg et al., 2010; Venkatesan and Rasgon, 2010). In Florida, Cx. nigripalpus is the dominant vector (Vitek et al., 2008; Kramer et al., 2008). This pattern is repeated at a global scale, with the dominant Culex mosquitoes in a given locality driving local WNV transmission (Kramer et al., 2008). Culex species tend to feed mainly on birds in the spring and summer, switching focus to take more mammalian bloodmeals in the fall, when outbreaks of WNV are most likely to occur among humans (Kilpatrick et al., 2006). In addition, several mosquito species not thought to be extremely important in WNV perpetuation, but potentially significant as “bridge” vectors (i.e. species that feed indiscriminantly) have been found infected, including Ae. albopictus and Ae. vexans (Turell et al., 2002). Several laboratory studies have established the competence of these vectors to transmit WNV (Turell et al., 2005), and field studies have detected both avian and mammalian blood in Ae. Vexans, although their relative importance in infecting humans and other hosts is currently unclear (Kilpatrick et al., 2005; Molaei and Andreadis, 2006). WNV has also been detected in Culex pipiens mosquitoes that have fed on human blood, indicating this mosquito may be the major bridge vector for infecting humans (Hamer et al., 2008). Although WNV may infect taxonomically diverse mosquito species throughout its range, certain Culex species appear to be critically important in WNV perpetuation in each geographic region where it persists.
Similarly, several bird species appear to be capable of generating sufficiently high viremias to infect mosquitoes and contribute to virus perpetuation. American Crow (Corvus brachyrhynchos) deaths near the Bronx Zoo in 1999 heralded the arrival of WNV, and these birds have served as useful sentinels since then (Eidson et al., 2001; Kramer and Bernard, 2001). Viremia in Crows reaches extremely high levels (>1010 PFU/mL of blood) and mortality is nearly uniform (McLean et al., 2001; Komar et al., 2003). Recently it has become clear that other massively roosting birds, mainly American Robins (Turdus migratorius) are important both in enzootic maintenance of WNV in highly active transmission foci, and in driving a feeding shift in Culex mosquitoes that increases human risk (Kilpatrick et al., 2006). Birds also have been implicated in spreading WNV throughout its distribution. Most importantly, migrating birds have been implicated in transportation of WNV from Africa throughout the Middle East and into Eurasia and within the Americas (Rappole et al., 2006; May et al., 2011; Zehender et al., 2011; Dusek et al., 2009). Clearly a wide variety of birds have been found infected by WNV, but the species most important to virus perpetuation may vary locally.
WNV is capable of being transmitted between a surprisingly large variety of hosts. In contrast, the related Dengue virus (DENV, Flaviviridae, Flavivirus) maintenance is mainly driven by single mosquito and host species (i.e. Aedes aegypti and human beings). By comparison, the ability of WNV to act as an ecological generalist is quite clear, and may account, in part, for its dispersal throughout much of the tropical and temperate world. The molecular and/or population mechanisms that form the basis for the relative lack of host-specificity exhibited by WNV are not fully understood, representing a critical area for future research.
2. Historical perspective
The evolutionary dynamics of WNV are of particular interest because of the emergence of the virus as a significant health burden in the last 20 years. Originally isolated in 1937 from the blood of a patient with fever in the West Nile district of Uganda (Smithburn et al., 1940), the first outbreaks of WNV disease were associated with relatively few cases, mild disease and rural settings (Hayes, 2001). Strikingly, an outbreak in Romania that occurred in 1996 and 1997 involved over 500 reported cases, with a case-fatality rate of approximately 10% (Tsai et al., 1989, 1998). This outbreak was also striking in that it occurred in a temperate urban region. Shortly thereafter, epidemics were reported in the south of Romania and in the Volga delta region of Russia. Additional recent epidemics have been reported in Russia, Israel, Greece, France, Hungary, Italy and others (Platonov, 2001; Bin et al., 2001; Papa et al., 2010; Balenghien et al., 2006; Depoortere et al., 2004; Kutasi et al., 2011; Bakonyi et al., 2006; Monaco et al., 2011). Generally, these outbreaks occurred in delta regions of major rivers including the Volga, Rhone and Danube. Comprehensive reviews of WNV in Europe have been published recently (Hubalek and Halouzka, 1999; Zeller and Schuffenecker, 2004).
In 1999, WNV was introduced into North America in the New York City area, resulting in an equine and avian epizootic, and associated human infection, morbidity and mortality (CDC, 1999). The virus rapidly spread throughout the mainland US and into Canada, Mexico, and as far south as Argentina. As has been amply noted, the introduction of WNV at a precisely defined time and place provided a relatively unique opportunity to prospectively observe the adaptation of an exotic RNA virus to an essentially naïve ecosystem. Accordingly, several studies have been conducted to examine the evolution of the virus since its introduction (Anderson et al., 2001; Ebel et al., 2001; Ebel et al., 2004; Beasley et al., 2003; Davis et al., 2005; Bertolotti et al., 2007; McMullen et al., 2011; Armstrong et al., 2011). Several molecular epidemiologic studies have examined nucleotide sequence data from WNV strains found in birds, mosquitoes and human beings. The most recent of these are discussed in detail below and others are reviewed elsewhere (Ebel and Kramer, 2009). The ability of WNV to act as an ecological generalist, in combination with recent increases in intercontinental travel and trade, appear to have facilitated its emergence on a global scale.
3. Taxonomy and classification
WNV is classified as a member of the Japanese Encephalitis complex of the Flaviviruses on the basis of serological cross-reactivity (Calisher et al., 1989). Within WNV, two major lineages (Lineage I and II) are currently accepted, with several additional lineages that differ from one another by 5–25% recently proposed (Vazquez et al., 2010; Bondre et al., 2007). Lineage I is distributed throughout much of the world, and is further subdivided into several clades, one of which includes NY-99 (clade Ia), the genotype introduced to the US in 1999, another includes Kunjin virus (clade Ib), a variant of West Nile virus endemic to Australia (Ebel and Kramer, 2009; Lanciotti et al., 1999; May et al., 2011). Lineage II was thought to be restricted to sub-Saharan Africa until recently. Since 2004, lineage II has been associated with outbreaks of West Nile virus in Western and Eastern Europe, and appears to have established endemic cycles in Spain and Greece (Papa et al., 2010; 2011; Bakonyi et al., 2006; Vazquez et al., 2010). Lineage III, also known as “Rabensburg virus”, is represented by several isolates made from the same region of the Czech Republic in 1997 and 1999 from Cx. pipiens mosquitoes, and 2006 from a pool of Ae. rossicus (Bakonyi et al., 2005; Hubalek et al., 2010). Lineage IV encompasses numerous isolates made in Russia, first detected in 1988 from a Dermacentor tick, and since isolated from mosquitoes and frogs in 2002 and 2005 in Russia (May et al., 2011). Lineage V comprises 13 isolates from India, collected from humans and Culex mosquitoes from the 1950s through 1980, which differ from other West Nile lineages by 20–25% at the nucleotide level (Bondre et al., 2007). Recent publications show these strains as basal to lineage I, comprising an independent cluster, lineage Ic (May et al., 2011). An additional, putative sixth lineage has been isolated in Spain from a pool of Cx. pipiens mosquitoes, and appears to be most closely related to lineage IV WNV (Vazquez et al., 2010). Additionally, Koutango virus (KOU), a Flavivirus isolated in Senegal, may represent a seventh lineage, as it is ~25% divergent from other WNV isolates, although it is currently categorized as a separate species (King et al., 2011). Human infection by KOU has not been reported, and its serological relationships to established WNV strains and transmission cycle are unclear, although partial cross neutralization with WNV and KUN has been shown (Charrel et al., 2003; Calisher et al., 1989). The distribution of all described lineages of WNV is shown in Fig. 1, by country where isolations have been made. The diversity of proposed WNV lineages worldwide reflects the diversity of the vectors involved in virus perpetuation and suggests that WNV or closely related agents have been introduced, and adapted to local transmission cycles on several occasions.
Fig. 1.
Worldwide map with countries where West Nile virus has been isolated colored as follows: Lineage Ia in light blue; lineage Ib in medium blue; lineage Ic in dark blue, lineage II in red, lineage III or “Rabensburg” virus in purple, lineage IV in orange, recent Spanish lineage (Vazquez et al., 2010) in green, and Koutango virus is colored yellow. Hatched coloring indicates more than one lineage has been isolated from that country. Lineage I distribution is adapted from May et al., 2011, other lineage isolates adapted from Charrel et al., 2003; Vazquez et al., 2010. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Taxonomic relationships are not entirely clear, and require reevaluation, especially with the recent proposal of so many new WNV lineages. In terms of nucleotide identity, they may be too disparately related to qualify as part of the same virus species, as the cutoffs proposed by researchers are >84% pairwise sequence identity (Kuno et al., 1998) or >79% for inclusion within a species (Ebel and Kramer, 2009; Charrel et al., 2003), although identity limits for inclusion within a lineage or species are generally arbitrary. According to the first estimate, lineage II WNV would have to be separated into its own species, as it has between 17% and 20% pairwise distance from lineage I, while the second pairwise distance might prevent proposed lineages III–VI from inclusion in WNV, as most show greater than 21% pairwise distance from the first two lineages at whole and partial genome levels (Vazquez et al., 2010; Bondre et al., 2007). These lineages appear to show some cross reactivity (Bondre et al., 2007; Bakonyi et al., 2005), may persist in similar transmission cycles, as most have been isolated from mosquitoes and birds, and appear to form a monophyletic clade when examined alongside Japanese encephalitis virus and Usutu virus (from the same serogroup) but a more systematic examination of relationships between the different lineages is warranted, as they have not been universally accepted (Ebel and Kramer, 2009; Vazquez et al., 2010). The relationships between these different lineages are further elucidated by Fig. 2, a phylogram based on the complete coding sequences for WNV lineages available in Genbank.
Fig. 2.
Radial phylogram showing relationships between different lineages of WNV. Complete coding sequences were downloaded from Genbank and aligned manually in BioEdit. Strains used and accession numbers are as follows: JEV, NC_001437; NY99, lineage Ia, NC_009942; Kunjin, paKUN, lineage Ib, AY274505.1; Indi804994, Indian lineage Ic, DQ256376.1; 956, lineage II, NC_001563; Rabensburg, lineage III, AY765264.1; RussianLEIV, lineage IV, strain Krnd88-190, AY277251.1; Koutango virus, EU082200.1. Bayesian phylogeny is shown, generated with MrBayes 3.1.2 run with a general time reversible (GTR) model with gamma shaped rate variation and invariable sites (Ronquist and Huelsenbeck, 2003). Two Markov chain Monte Carlo (MCMC) tree searches of 5000,000 generations each were run in parallel with sampling one in every 1000 trees. Radial 50% majority-rule consensus tree is shown based on the last 3750 trees. Posterior probabilities are given as numbers at each node.
Lineage I has been subject to the most intensive study. It is now distributed worldwide, and includes the genotype introduced to the US in 1999 (NY99). Some genotypes appear to be more pathogenic than others, for example NY99 shows enhanced pathogenesis in birds (see below), whereas Kunjin virus (clade Ib) is associated with attenuated infection and decreased neuroinvasion (Brault et al., 2007; Daffis et al., 2011). Lineage II is mainly associated with less severe disease, and less frequent neuroinvasion. However, recent reports describe encephalitis produced by infection with lineage II strains in both humans and horses in South Africa (Venter and Swanepoel, 2010; Venter et al., 2009). Lineage III has only been isolated from mosquitoes, and did not produce mortality in adult mice infected subcutaneously, intraperitoneally, or intracranially (Hubalek et al., 2010). Lineage V viruses from India are also associated with lower virulence (Davis et al., 2005; Bondre et al., 2007). WNV has thus clearly adapted to a wide array of transmission cycles and environments worldwide. This process of migration and adaptation to these environments has produced the currently observed lineages. Additional studies are required in order to define differences in virulence, neuroinvasiveness, natural hosts and vectors, and basic ecology for each putative lineage.
4. Molecular epidemiology
Upon its introduction to the United States, WNV was initially recognized by sequence comparisons and phylogenetic analysis (Lanciotti et al., 1999). The genotype introduced to the New World, dubbed NY99 for its initial isolation in New York in 1999, is most closely related to isolates made in Israel in 1998 and Hungary in 2003 (Zehender et al., 2011; Lanciotti et al., 1999; Jia et al., 1999). Initial sequence analysis of the WNV strains isolated during the first two years in New England showed a remarkable amount of genetic conservation, indicating a single point of introduction and very little diversification in WNV populations during this time period (Anderson et al., 2001; Ebel et al., 2001; Lanciotti et al., 1999; reviewed in Kramer et al., 2008; Ebel and Kramer, 2009). Subsequently, an additional subtype of WNV, WN02, with an amino acid substitution in the envelope protein, A159V, was detected in samples isolated in Texas (Beasley et al., 2003). From 2001 to 2003, WN02 rapidly displaced NY99, becoming the dominant genotype in North America (Ebel et al., 2004; Davis et al., 2005). WN02 strains require a shorter extrinsic incubation period in mosquitoes, which appears to be the mechanism for its increased fitness relative to NY99 (Ebel et al., 2004; Moudy et al., 2007). Thus, shortly after WNV was introduced into North America, the process of evolution led to increases in the basic reproductive rate of this pathogen.
As WNV became established throughout North America, the genetic diversity present in different types of data sets has led to insights into its emergence and expansion. Studies have found increased genetic diversity in mosquitoes relative to birds (Bertolotti et al., 2007; Amore et al., 2010), perhaps due to different selective pressure from the immune pathways used by these different hosts, which will be discussed in the section on genetic diversity below (Brackney et al., 2009). Genetic diversity and therefore estimated virus population size appeared to initially increase yearly after introduction to the US, although studies suggest this may be leveling off as WNV becomes established endemically (Bertolotti et al., 2007, 2008; Amore et al., 2010; Snapinn et al., 2007).
Several studies (Armstrong et al., 2011)showed a lack of geographical partitioning among sequences, especially those that examined sequence data from isolates sampled immediately after the introduction of WNV to novel environments and relied primarily on envelope sequences (Bertolotti et al., 2007, 2008; Davis et al., 2007). Recent studies, relying on full genome sequences and encompassing samples taken over a number of years after introduction of WNV uncovered more evidence for geographical structure to samples (McMullen et al., 2011; Armstrong et al., 2011; Herring et al., 2007; Grinev et al., 2008). A recent analysis indicates sequences from the envelope coding region may not be the most phylogenetically informative, and suggests NS3 or NS5 may be better partial sequences for reconstructing the phylogenetic relationships between different isolates, and can provide reconstructions that more closely resemble those resulting from whole genome sequences (Gray et al., 2010). Several distinct genetic variants of WNV have arisen in certain geographical areas, such as Texas (McMullen et al., 2011; Davis et al., 2004). One attenuated genetic lineage seems to have become extinct after being detected over the course of two years (Davis et al., 2005, 2004; Ebel and Kramer, 2009; Ebel, 2010). Another distinctive genotype, SW/WN03, contains several amino acid changes relative to other WN02 and is recently reported to be spreading through numerous states, although the phenotype associated with this new genotype has not been characterized (McMullen et al., 2011). It may be that more genetic changes accumulated in these WNV populations as they adapted to local transmission cycles.
Recent studies using full genome sequences of WNV from isolates made globally have uncovered phylogeographical influences on clade 1a distribution (May et al., 2011; Zehender et al., 2011). This clade seems to have a common ancestor that existed in sub-Saharan Africa in the early 20th century, which had multiple migrations to both Western and Eastern European countries in the 1970s and 1980s, and single introductions to India and Australia around the same time (May et al., 2011; Zehender et al., 2011). The patterns of distribution from Africa to Europe seem to follow white stork migration routes, indicating a possibly important role for this bird species in the spread of WNV into that continent (Zehender et al., 2011). Other mosquito borne Flaviviruses have also apparently originated in Africa, including yellow fever and dengue virus (Bryant et al., 2007; Gaunt et al., 2001; Holmes and Twiddy, 2003).
Arboviruses are unique in that they require replication in taxonomically divergent hosts – vertebrates and invertebrates (Weaver, 2006). This requirement is thought to restrict the amount of mutation that can occur in arboviruses, relative to single host viruses (Jenkins et al., 2002). Experimental studies have shown lower mutation rates in viruses serially passaged in alternating hosts, relative to those passaged in a single host type (Jerzak et al., 2007; Coffey et al., 2008; Coffey and Vignuzzi, 2011). To date, numerous studies have shown purifying or negative selection is dominant in arbovirus populations, including West Nile virus (Bertolotti et al., 2007, 2008; McMullen et al., 2011; Armstrong et al., 2011; Amore et al., 2010; Jerzak et al., 2005). In WNV phylogenetic analyses, only a few genetic changes have been identified that appear to be the subject of positive selective pressure. These include the amino acid residue associated with increased pathogenesis among North American birds, NS3 T249P and a mutation to NS4A, or the 2 K protein (V135M or V9M) (Armstrong et al., 2011; Brault et al., 2007). The valine to methionine mutation in NS4A/2K is associated with OAS1b resistance, resistance to the flavivirus specific antiviral lycorine, and ability to overcome super-infection exclusion in replicon containing cell lines, which appears to be related to enhanced viral RNA synthesis (Mertens et al., 2010; Zou et al., 2009a,b). Adaptive evolution has also been detected at amino acid sites: E-V431I, NS2A-A224V/T, NS4A-A85T, NS5-K314R, and NS5-R422K although the functional significances of these sites are unclear (May et al., 2011; McMullen et al., 2011). Thus, several of the encoded WNV proteins are subject to positive selection that may lead to increased transmission efficiency and the likelihood for perpetuation in different transmission cycles.
Synonymous changes to the WNV genome could also impact its pathogenesis and evolution. Numerous synonymous changes were associated with the new genotype, WN02, and although some of these are assumed to have become fixed by association with other mutations that might confer a selective advantage, they could also exert an effect through codon bias or changes to the RNA genomic structure. The 5′ and 3′ untranslated regions are well conserved and have essential roles during viral replication (Khromykh et al., 2001; Zhang et al., 2008). Additional studies have shown that other RNA genome structures present in the capsid coding region can operate to upregulate flaviviral replication (Tuplin et al., 2011; Clyde and Harris, 2006). Additionally, codon bias in flaviviruses reflect the host usage (vertebrate only and alternating seem to display vertebrate codon biases, invertebrate only have more invertebrate bias), so examination of codon bias for a given virus can provide insight into its evolutionary history (Schubert and Putonti, 2010). Additional studies are required in order to determine the extent to which nonsynonymous variation impact RNA genomic structure in a way that influences WNV phenotype.
5. Within-host population dynamics
Molecular epidemiologic studies such as those discussed in the preceding section have provided insights into the selective forces that act on WNV and shown clearly that the virus is a dynamic, evolving entity with the capacity to adapt to a wide range of hosts and environments. These findings have stimulated studies aimed at understanding the viral population genetic mechanisms that account for this, and to assess whether the two very different kinds of host required for WNV perpetuation (mosquitoes and birds) influence the WNV population in different ways. Early studies suggested that within hosts, WNV forms a genetically complex distribution of mutants that vary in their degree of nucleotide divergence from the population consensus sequence. Further, Jerzak et al. (2005) showed that whereas WNV populations in naturally infected birds are relatively genetically homogeneous and purifying selection is strong, in field collected WNV infected mosquitoes they are very diverse, and purifying selection seems to be relaxed. The observations were supported by a series of laboratory studies that passed WNV in colonized mosquitoes and chickens (Jerzak et al., 2007), and cultured cells (Ciota et al., 2007). Importantly, the mosquito passed virus was inoculated intrathoracically and whole mosquitoes were triturated to obtain passed WNV, bypassing putative transmission barriers in the midgut and salivary glands (Hardy et al., 1983; Ciota et al., 2008). A highly similar study conducted using virus obtained from mosquito saliva failed to confirm these results raising the possibility that infection of, or escape from salivary glands might constitute a population bottleneck in the WNV system (Ciota et al., 2008; Ciota and Kramer, 2010). Nonetheless, several studies have clearly established that mosquitoes and birds exert different evolutionary pressures on WNV.
The mechanistic basis for this difference has been addressed from a variety of perspectives. First, vertebrates and invertebrates respond to virus infections differently. In vertebrates, the earliest responses to infection by RNA viruses are dominated by type I interferon (IFNα/β). This response is triggered when RIG-I senses dsRNA in host cell cytosol, initiating signaling cascades that ultimately result in an antiviral state in the cell (reviewed in (Daffis et al., 2009)). Therefore, in vertebrates, WNV may be required to essentially “outrun” the antiviral state in infected individuals. This would result in strong purifying selection that has been observed after virus replication in these hosts (Ding, 2010; Jerzak et al., 2007), where presumably all or nearly all nonsynonymous mutation results in genomes of diminished fitness.
In contrast, insects respond to virus infection mainly through RNA interference (RNAi), which is also triggered by dsRNA within cells (reviewed in (Ding, 2010)). Ultimately, virus-derived small-interfering RNAs (viRNAs) are loaded into the RNA induced silencing complex (RISC) to degrade target viral RNA in a sequence-specific manner. Therefore, the antiviral state in mosquito cells seems to drive WNV diversification through a mechanism akin to negative, frequency-dependant selection, wherein rare genotypes (i.e. those that do not match common guide sequences loaded into the RISC) are favored because they are less efficiently degraded (Brackney et al., 2009). The precise relationship between this mechanism and the observed lack of purifying selection in mosquitoes has not been resolved or adequately addressed, and may represent two sides of the same coin. Overall, WNV population biology seems to be dominated by largely opposing forces that exist within its natural transmission cycle. Specifically, WNV undergoes alternating cycles of genetic expansion in mosquitoes that generates novel genotypes, and purification in birds that ensures that high fitness is maintained.
Other forces that influence WNV genetic diversity also have been examined recently. Population bottlenecks can stochastically reduce population diversity and lead to fitness declines through the action of Muller’s ratchet (Duarte et al., 1992). Convention holds that in natural transmission cycles, arboviruses undergo population bottlenecks as they pass through mosquitoes, where they seem to sequentially infect the epithelium of the mosquito midgut, peripheral tissues and ultimately the salivary glands, from which they are released into salivary secretions that are inoculated during mosquito feeding (Hardy et al., 1983). Such population bottlenecks have been described for alphaviruses and flaviviruses. Studies examining early mosquito infection by Venezuelan equine encephalitis virus (VEEV; Togaviridae, Alphavirus) and WNV demonstrated that only a few midgut cells are susceptible to infection, suggesting that anatomical bottlenecks may reduce genetic variability (Smith et al., 2008). Conversely, identical non-consensus WNV genomes have been detected in intrahost populations infecting birds in a single transmission focus, suggesting that population bottlenecks may not be as restrictive as had been assumed (Jerzak et al., 2005), and defective DENV genomes appear to perpetuate in transmission cycles through complementation (Aaskov et al., 2006). Supporting this, Brackney et al. recently failed to document significant population bottlenecks during infection of Cx. quinquefasciatus mosquitoes by WNV (Brackney et al., 2011). It may be that the importance of bottlenecks during arbovirus transmission is a function of the specific virus–host system under study, and not consistent across systems.
6. Genetic correlates of pathogenesis and fitness
Molecular genetic and phenotypic studies of WNV mutants and engineered clones have revealed multiple genetic variations correlated with increased or decreased pathogenicity. WNV was long thought to be a less pathogenic flavivirus, with sporadic epidemics producing little or no mortality in human populations up until the early 1990s (Hayes, 2001). The recent introduction of WNV to the United States was marked by large die offs in bird populations, and a wave of epidemic cases among humans (Murray et al., 2010a). Studies have identified a single amino acid substitution in the NS3 helicase coding region, T249P, that increased morbidity and viral load in American crows, and appeared to be under selective pressure in areas with multiple genotypes present (Brault et al., 2007, 2004). After establishment of this initial pathogenic strain of WNV across the US, phylogenetic analysis of WNV sequences detected a new genotype, WN02, which displaced the initial strain NY99 in less than 4 years (Ebel et al., 2004; Davis et al., 2005). This new genotype had a single amino acid substitution in the envelope coding protein, V159A, that significantly decreased the extrinsic incubation time from virus infection until transmission by Cx. pipiens mosquitoes important vectors in the northeastern United States (Moudy et al., 2007; Kilpatrick et al., 2008). This mutation occurs nearby the envelope glycosylation motif for WNV, which is at nucleotide positions 154–156 in the envelope coding sequence.
Envelope protein glycosylation sites are conserved throughout the genus Flavivirus, although natural variation in glycosylation is present in populations of WNV (Adams et al., 1995; Berthet et al., 1997; Shirato et al., 2004; Hanna et al., 2005). An N linked glycosylation site at position 154 in the envelope protein has been associated with increased neuroinvasiveness for WNV in mice, and increased virulence and viremia in young chicks (Shirato et al., 2004; Beasley et al., 2005; Murata et al., 2010). Envelope protein glycosylation is also necessary for efficient transmission by Cx. pipiens, Cx. tarsalis, and Cx. quinquefasciatus, but not Cx. pipiens pallens, thus it influences vector competence in a species specific way (Murata et al., 2010; Moudy et al., 2009). Glycosylation patterns from virus propagated in insect versus vertebrate cells also seem to influence the ability of envelope protein to modulate innate immune response, and leads to different patterns of infectivity and propagation in different cell types, thus the role of glycosylation is also host specific (Hanna et al., 2005; Arjona et al., 2007).
The mechanism behind envelope protein glycosylation and modulation of WNV activity could be related to a number of different phenomena. The ability of WNV envelope to suppress dsRNA activated innate immune response is dependent on glycosylation status, which leads to increased inflammatory cytokine production for cells infected with virus lacking glycosylation (Arjona et al., 2007). Envelope glycosylation status influences ability to survive in lower pH environments (Beasley et al., 2005; Langevin et al., 2011). Genomes lacking the envelope glycosylation site have decreased replication, which may be related to budding of mature virions from the lumen of the endoplasmic reticulum rather than the plasma membrane (Berthet et al., 1997; Shirato et al., 2004; Li et al., 2006). Abolishing the N linked glycosylation site on WNV envelope also influences receptor interactions, as it decreases greatly the ability of WNV to bind DC-SIGNR (Davis et al., 2006). One or a combination of these mechanisms, or perhaps a mechanism yet to be uncovered may explain the increased virulence of WNV with envelope N-linked glycosylation.
Strains associated with greater neuroinvasiveness and pathogenesis in mice and humans tend to be better controllers of interferon mediated responses (Daffis et al., 2011, 2009). Numerous WNV proteins may modulate the interferon signaling cascade in vertebrate hosts, including all nonstructural coding proteins (NS1: Wilson et al., 2008, NS2A/B: Liu et al., 2006, NS3: Liu et al., 2005, NS4A/B: Muñoz-Jordán et al., 2003 NS5: Laurent-Rolle et al., 2010; reviewed, Diamond et al., 2009; Samuel and Diamond, 2006). With the advent of reverse genetics, recent studies have determined distinct amino acid changes in certain residues that are correlated with changed ability to control host immune responses. For example, a single residue at position 653 in NS5 appears to be responsible for the enhanced ability of NY99 like viruses to suppress interferon response. In North American genotype 1a viruses, position 653 of NS5 is a phenylalanine, whereas in the less pathogenic Kunjin virus, this position is a serine, and if these residues are switched through reverse genetics, suppression is enhanced for Kunjin and depleted for NY99 (Laurent-Rolle et al., 2010). Another example comes from studies of the host factor OAS1b which appears to confer natural resistance to WNV (Samuel and Diamond, 2006; Lucas et al., 2003). Virus cultivated in the presence of OAS1b can circumvent this factor by mutating at several residues, including NS3-S365G, which seems to lower the requirement of ATP for the ATPase dependent cleavage activity of this protease, and 2K-V9M, which generally enhances viral RNA synthesis (Mertens et al., 2010). Virus strains with higher rates of replication may be positively selected (Armstrong et al., 2011). Studies like this that correlate genotype with phenotype, and determine the underlying mechanisms, should expand our understanding of virus pathogenesis and the forces shaping the emergence of pathogenic phenotypes.
Attenuated genotypes of WNV emerged during the course of its spread across the United States. In Texas, a number of small plaque variants of WNV that displayed reduced neuroinvasiveness in mice were detected in 2003 (Davis et al., 2004). Comparison to NY99 strain followed by introduction of similar mutations into an infectious clone identified a combination of mutations to NS4, NS5, and the 3′ UTR as being necessary for the attenuated phenotype found in one bird sample (Davis et al., 2007, 2004). Further analysis of other samples from the same region found that different amino acid substitutions in these strains appear to confer attenuation, indicating multiple pathways towards attenuated phenotypes (May et al., 2010). A single amino acid substitution in the central portion of NS4B, C102S, was enough to attenuate neurovirulence in mice (Wicker et al., 2006). Lineage II WNV has been associated with encephalitis and more severe disease only rarely, but comparison of the strains isolated from patients with more severe disease to less virulent strains indicates an enhanced role for NS proteins in determining virulence, relative to structural proteins, similar to findings for lineage I (Botha et al., 2008).
7. Conclusions and future research directions
In recent decades, WNV has emerged as one of the most intensely studied arthropod borne viruses. The spread of WNV throughout North America and periodic outbreaks in Eastern and Western Europe have enhanced worldwide interest in understanding viral, host, and ecological factors that result in outbreaks. Due to the availability of an increasing number of complete genome sequences (as of October 12, 2011, 479 are currently available on GenBank) major advances have occurred in understanding its molecular epidemiology, particularly in North America. Collectively, these studies have clearly demonstrated that WNV is a dynamic virus population that is able to perpetuate in and adapt to a wide range of ecological settings through mutation and selection. In addition, since the virus transmission cycle is relatively tractable in the laboratory using colonized mosquitoes and captive wild or domestic birds, experimental studies have provided insights into how different components of the transmission cycle influence virus population genetics and evolution. These studies have shown that mosquitoes drive WNV diversification through their innate antivirus response and because purifying selection is weak in these hosts, provide a reservoir of genetic diversity that allows the observed adaptation. In contrast, infection of birds ensures that the resulting variants are of high fitness through strong purifying selection. The processes that underpin WNV evolution are thus beginning to be understood in greater detail.
Several important areas for future research, however, remain. First, persistent infection of WNV in humans and vertebrates is emerging as a significant health issue in particular regions of the US (Murray et al., 2010b). The extent to which viral genetic and population determinants influence this has not been adequately addressed. In cell culture, establishment of persistent infection with Flaviviruses can occur with subgenomic replicons or the development of defective interfering particles (DIPs) (Zou et al., 2009b; Yoon et al., 2006). A second pressing matter is a reevaluation of the serological relationships within the Japanese encephalitis serogroup. Molecular genetic studies have proposed numerous lineages of WNV beyond the traditional two lineages recognized previously. The basic biology, transmission cycle, host range and pathogenicity of these putative lineages should also be studied further. Additionally, numerous amino acid residues may be under positive selection, but the roles of these residues are still unclear. Reverse genetic studies should be undertaken to determine the influence of these changes on WNV biology. With the advent of new sequencing technologies, our ability to design and conduct experiments into immune responses of hosts to viral infection and viral population biology has greatly increased. The role of RNAi in generating viral diversity, the potential bottlenecks associated with the WNV transmission cycle, and the interaction of individuals within a viral population may all become better understood with deep sequencing approaches. Finally, more collaboration between people studying ecology, epidemiology, molecular genetics, and pathology of WNV could lead to greater insight into its overall biology.
We have highlighted major advances in WNV biology over the past decade, including understanding of host specific selective pressures on viral populations, genotypic correlates with pathogenic phenotypes, and phylogenetic relationships between different lineages, strains, and genotypes. Molecular epidemiology studies continue to elucidate the spread and evolutionary change that is ongoing in WNV populations.
References
- Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science. 2006;311:236. doi: 10.1126/science.1115030. [DOI] [PubMed] [Google Scholar]
- Adams S, Broom A, Sammels L, Hartnett A, Howard M, Coelen R, Mackenzie J, Hall R. Glycosylation and antigenic variation among Kunjin virus isolates. Virology. 1995;206:49–56. doi: 10.1016/s0042-6822(95)80018-2. [DOI] [PubMed] [Google Scholar]
- Ambrose RL, Mackenzie JM. West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion. J Virol. 2011;85:2723. doi: 10.1128/JVI.02050-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amore G, Bertolotti L, Hamer GL, Kitron UD, Walker ED, Ruiz MO, Brawn JD, Goldberg TL. Multi-year evolutionary dynamics of West Nile virus in suburban Chicago, USA, 2005–2007. Philos Trans R Soc Lond B Biol Sci. 2010;365:1871–1878. doi: 10.1098/rstb.2010.0054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson JF, Vossbrinck CR, Andreadis TG, Iton A, Beckwith WH, Mayo DR. A phylogenetic approach to following West Nile virus in Connecticut. Proc Natl Acad Sci. 2001;98:12885. doi: 10.1073/pnas.241472398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol. 2007;179:8403. doi: 10.4049/jimmunol.179.12.8403. [DOI] [PubMed] [Google Scholar]
- Armstrong PM, Vossbrinck CR, Andreadis TG, Anderson JF, Pesko KN, Newman RM, Lennon NJ, Birren BW, Ebel GD, Henn MR. Molecular evolution of West Nile virus in a northern temperate region: Connecticut, USA 1999–2008. Virology. 2011;417:203–210. doi: 10.1016/j.virol.2011.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP. Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation. J Immunol. 2011;187:424. doi: 10.4049/jimmunol.1100750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bakonyi T, Hubálek Z, Rudolf I, Nowotny N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis. 2005;11:225–231. doi: 10.3201/eid1102.041028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bakonyi T, Ivanics E, Erdelyi K, Ursu K, Ferenczi E, Weissenbock H, Nowotny N. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis. 2006;12:618–623. doi: 10.3201/eid1204.051379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balenghien T, Fouque F, Sabatier P, Bicout D. Horse-, bird-, and human-seeking behavior and seasonal abundance of mosquitoes in a West Nile virus focus of southern France. J Med Entomol. 2006;43:936–946. doi: 10.1603/0022-2585(2006)43[936:hbahba]2.0.co;2. [DOI] [PubMed] [Google Scholar]
- Beasley DWC, Davis CT, Guzman H, Vanlandingham DL, Travassos da Rosa A, Parsons RE, Higgs S, Tesh RB, Barrett ADT. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology. 2003;309:190–195. doi: 10.1016/s0042-6822(03)00150-8. [DOI] [PubMed] [Google Scholar]
- Beasley DWC, Whiteman MC, Zhang S, Huang CYH, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett ADT. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol. 2005;79:8339. doi: 10.1128/JVI.79.13.8339-8347.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bell JA, Brewer CM, Mickelson NJ, Garman GW, Vaughan JA. West Nile virus epizootiology, central Red River Valley, North Dakota and Minnesota, 2002–2005. Emerg Infect Dis. 2006;12:1245–1247. doi: 10.3201/eid1208.060129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bernard K, Maffei J, Jones S, Kauffman E, Ebel G, Dupuis A. West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis. 2001;7:679. doi: 10.3201/eid0704.010415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berthet F, Zeller H, Drouet M, Rauzier J, Digoutte J, Deubel V. Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol. 1997;78:2293. doi: 10.1099/0022-1317-78-9-2293. [DOI] [PubMed] [Google Scholar]
- Bertolotti L, Kitron U, Goldberg TL. Diversity and evolution of West Nile virus in Illinois and the United States, 2002–2005. Virology. 2007;360:143–149. doi: 10.1016/j.virol.2006.10.030. [DOI] [PubMed] [Google Scholar]
- Bertolotti L, Kitron UD, Walker ED, Ruiz MO, Brawn JD, Loss SR, Hamer GL, Goldberg TL. Fine-scale genetic variation and evolution of West Nile Virus in a transmission “hot spot” in suburban Chicago, USA. Virology. 2008;374:381–389. doi: 10.1016/j.virol.2007.12.040. [DOI] [PubMed] [Google Scholar]
- Bin H, Grossman Z, Pokamunski S, Malkinson M, Weiss L, Duvdevani P, Banet C, Weisman Y, Annis E, Gandaku D. West Nile Fever in Israel 1999–2000. Ann N Y Acad Sci. 2001;951:127–142. doi: 10.1111/j.1749-6632.2001.tb02691.x. [DOI] [PubMed] [Google Scholar]
- Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res. 2009 doi: 10.1016/j.antiviral.2009.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bondre VP, Jadi R, Mishra A, Yergolkar P, Arankalle V. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007;88:875. doi: 10.1099/vir.0.82403-0. [DOI] [PubMed] [Google Scholar]
- Botha EM, Markotter W, Wolfaardt M, Paweska JT, Swanepoel R, Palacios G, Nel LH, Venter M. Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis. 2008;14:222. doi: 10.3201/eid1402.070457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brackney DE, Beane JE, Ebel GD. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog. 2009;5:e1000502. doi: 10.1371/journal.ppat.1000502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brackney DE, Pesko KN, Brown IK, Deardorff ER, Kawatachi J, Ebel GD. West Nile virus genetic diversity is maintained during transmission by Culex pipiens quinquefasciatus mosquitoes. PLoS One. 2011;6:e24466. doi: 10.1371/journal.pone.0024466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brault AC, Huang CYH, Langevin SA, Kinney RM, Bowen RA, Ramey WN, Panella NA, Holmes EC, Powers AM, Miller BR. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet. 2007;39:1162–1166. doi: 10.1038/ng2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brault AC, Langevin SA, Bowen RA, Panella NA, Biggerstaff BJ, Miller BR, Komar N. Differential virulence of West Nile strains for American crows. Emerg Infect Dis. 2004;10:2161. doi: 10.3201/eid1012.040486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brinton MA. Molecular Biology of West Nile Virus. In: Diamond M, editor. West Nile Encephalitis Virus Infection: Viral Pathogenesis and the Host Immune Response. Springer; New York: 2009. [Google Scholar]
- Brinton MA. Host factors involved in West Nile virus replication. Ann N Y Acad Sci. 2001;951:207–219. doi: 10.1111/j.1749-6632.2001.tb02698.x. [DOI] [PubMed] [Google Scholar]
- Bryant JE, Holmes EC, Barrett ADT. Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog. 2007;3:e75. doi: 10.1371/journal.ppat.0030075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol. 1989;70:37. doi: 10.1099/0022-1317-70-1-37. [DOI] [PubMed] [Google Scholar]
- CDC. Outbreak of West Nile-like viral encephalitis—New York, 1999. Morb Mortal Wkly Rep. 1999;48:845–849. [PubMed] [Google Scholar]
- Charrel R, Brault A, Gallian P, Lemasson JJ, Murgue B, Murri S, Pastorino B, Zeller H, De Chesse R, De Micco P. Evolutionary relationship between Old World West Nile virus strains: evidence for viral gene flow between Africa, the Middle East, and Europe. Virology. 2003;315:381–388. doi: 10.1016/s0042-6822(03)00536-1. [DOI] [PubMed] [Google Scholar]
- Cheng G, Cox J, Wang P, Krishnan MN, Dai J, Qian F, Anderson JF, Fikrig E. A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell. 2010;142:714–725. doi: 10.1016/j.cell.2010.07.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chu JJ, Ng ML. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol. 2004a;78:10543–10555. doi: 10.1128/JVI.78.19.10543-10555.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chu JJ, Ng ML. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J Biol Chem. 2004b;279:54533–54541. doi: 10.1074/jbc.M410208200. [DOI] [PubMed] [Google Scholar]
- Ciota AT, Kramer LD. Insights into arbovirus evolution and adaptation from experimental studies. Viruses. 2010;12:2594–2617. doi: 10.3390/v2122594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ciota AT, Lovelace AO, Jia Y, Davis LJ, Young DS, Kramer LD. Characterization of mosquito-adapted West Nile virus. J Gen Virol. 2008;89:1633. doi: 10.1099/vir.0.2008/000893-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ciota AT, Ngo KA, Lovelace AO, Payne AF, Zhou Y, Shi PY, Kramer LD. Role of the mutant spectrum in adaptation and replication of West Nile virus. J Gen Virol. 2007;88:865–874. doi: 10.1099/vir.0.82606-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clyde K, Harris E. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol. 2006;80:2170–2182. doi: 10.1128/JVI.80.5.2170-2182.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coffey LL, Vasilakis N, Brault AC, Powers AM, Tripet F, Weaver SC. Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci. 2008;105:6970. doi: 10.1073/pnas.0712130105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coffey LL, Vignuzzi M. Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol. 2011;85:1025. doi: 10.1128/JVI.01918-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daffis S, Lazear HM, Liu WJ, Audsley M, Engle M, Khromykh AA, Diamond MS. The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response. J Virol. 2011;85:5664. doi: 10.1128/JVI.00232-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daffis S, Suthar MS, Gale M, Jr, Diamond MS. Measure and countermeasure: type I IFN (IFN-α/β) antiviral response against West Nile Virus. J Innate Immun. 2009;1:435. doi: 10.1159/000226248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis CT, Beasley DWC, Guzman H, Siirin M, Parsons RE, Tesh RB, Barrett ADT. Emergence of attenuated West Nile virus variants in Texas, 2003. Virology. 2004;330:342–350. doi: 10.1016/j.virol.2004.09.016. [DOI] [PubMed] [Google Scholar]
- Davis CT, Li L, May FJ, Bueno R, Jr, Dennett JA, Bala AA, Guzman H, Elizondo-Quiroga D, Tesh RB, Barrett AD. Genetic stasis of dominant West Nile virus genotype, Houston, Texas. Emerg Infect Dis. 2007;13:601. doi: 10.3201/eid1304.061473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis CW, Nguyen HY, Hanna SL, Sánchez MD, Doms RW, Pierson TC. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol. 2006;80:1290. doi: 10.1128/JVI.80.3.1290-1301.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis CT, Ebel GD, Lanciotti RS, Brault AC, Guzman H, Siirin M, Lambert A, Parsons RE, Beasley DW, Novak RJ, Elizondo-Quiroga D, Green EN, Young DS, Stark LM, Drebot MA, Artsob H, Tesh RB, Kramer LD, Barrett AD. Phylogenetic analysis of North American West Nile virus isolates, 2001–2004: evidence for the emergence of a dominant genotype. Virology. 2005;342:252–265. doi: 10.1016/j.virol.2005.07.022. [DOI] [PubMed] [Google Scholar]
- Depoortere E, Kavle J, Keus K, Zeller H, Murri S, Legros D. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. Tropical Med Int Health. 2004;9:730–736. doi: 10.1111/j.1365-3156.2004.01253.x. [DOI] [PubMed] [Google Scholar]
- Diamond MS, Mehlhop E, Oliphant T, Samuel MA. The host immunologic response to West Nile encephalitis virus. Front Biosci. 2009;14:3024–3034. doi: 10.2741/3432. [DOI] [PubMed] [Google Scholar]
- Ding SW. RNA-based antiviral immunity. Nat Rev Immunol. 2010;10(9):632–644. doi: 10.1038/nri2824. [DOI] [PubMed] [Google Scholar]
- Duarte E, Clarke D, Moya A, Domingo E, Holland J. Rapid fitness losses in mammalian RNA virus clones due to Muller’s ratchet. Proc Natl Acad Sci. 1992;89:6015. doi: 10.1073/pnas.89.13.6015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dusek RJ, McLean RG, Kramer LD, Ubico SR, Dupuis AP, Ebel GD, Guptill SC. Prevalence of West Nile virus in migratory birds during spring and fall migration. Am J Trop Med Hyg. 2009;81:1151. doi: 10.4269/ajtmh.2009.09-0106. [DOI] [PubMed] [Google Scholar]
- Ebel GD. Update on Powassan virus: emergence of a North American tick-borne flavivirus. Annu Rev Entomol. 2010;55:95–110. doi: 10.1146/annurev-ento-112408-085446. [DOI] [PubMed] [Google Scholar]
- Ebel GD, Kramer LD. West Nile virus: molecular epidemiology and diversity. In: Diamond MS, editor. West Nile Encephalitis Virus Infection. Springer; 2009. pp. 25–43. [Google Scholar]
- Ebel GD, Dupuis AP, 2nd, Ngo K, Nicholas D, Kauffman E, Jones SA, Young D, Maffei J, Shi PY, Bernard K, Kramer LD. Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg Infect Dis. 2001;7(4):650–653. doi: 10.3201/eid0704.010408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebel GD, Carricaburu J, Young D, Bernard KA, Kramer LD. Genetic and phenotypic variation of West Nile virus in New York, 2000–2003. Am J Trop Med Hyg. 2004;71:493–500. [PubMed] [Google Scholar]
- Eidson M, Komar N, Sorhage F, Nelson R, Talbot T, Mostashari F, McLean R. Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis. 2001;7:615. doi: 10.3201/eid0704.010402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans JD, Crown RA, Sohn JA, Seeger C. West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol. 2011;24:253–263. doi: 10.1089/vim.2010.0126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaunt MW, Sall AA, Lamballerie Xd, Falconar AKI, Dzhivanian TI, Gould EA. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol. 2001;82:1867–1876. doi: 10.1099/0022-1317-82-8-1867. [DOI] [PubMed] [Google Scholar]
- Goldberg TL, Anderson TK, Hamer GL. West Nile virus may have hitched a ride across the Western United States on Culex tarsalis mosquitoes. Mol Ecol. 2010;19:1518–1519. doi: 10.1111/j.1365-294X.2010.04578.x. [DOI] [PubMed] [Google Scholar]
- Gray R, Veras N, Santos L, Salemi M. Evolutionary characterization of the West Nile Virus complete genome. Mol Phylogenet Evol. 2010;56:195–200. doi: 10.1016/j.ympev.2010.01.019. [DOI] [PubMed] [Google Scholar]
- Grinev A, Daniel S, Stramer S, Rossmann S, Caglioti S, Rios M. Genetic variability of West Nile virus in US blood donors, 2002–2005. Emerg Infect Dis. 2008;14:436. doi: 10.3201/eid1403.070463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamer GL, Kitron UD, Brawn JD, Loss SR, Ruiz MO, Goldberg TL, et al. Culex Pipiens (Diptera: Culicidae): a bridge vector of West Nile virus to humans. J Med Entomol. 2008;45:125–128. doi: 10.1603/0022-2585(2008)45[125:cpdcab]2.0.co;2. [DOI] [PubMed] [Google Scholar]
- Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J Virol. 2005;79:13262. doi: 10.1128/JVI.79.21.13262-13274.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hardy JL, Houk EJ, Kramer LD, Reeves WC. Intrinsic factors affecting vector competence of mosquitoes for arboviruses. Annu Rev Entomol. 1983;28:229–262. doi: 10.1146/annurev.en.28.010183.001305. [DOI] [PubMed] [Google Scholar]
- Hayes CG. West Nile virus: Uganda, 1937, to New York City, 1999. Ann N Y Acad Sci. 2001;951:25–37. doi: 10.1111/j.1749-6632.2001.tb02682.x. [DOI] [PubMed] [Google Scholar]
- Herring BL, Bernardin F, Caglioti S, Stramer S, Tobler L, Andrews W, Cheng L, Rampersad S, Cameron C, Saldanha J. Phylogenetic analysis of WNV in North American blood donors during the 2003–2004 epidemic seasons. Virology. 2007;363:220–228. doi: 10.1016/j.virol.2007.01.019. [DOI] [PubMed] [Google Scholar]
- Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol. 2003;3:19–28. doi: 10.1016/s1567-1348(03)00004-2. [DOI] [PubMed] [Google Scholar]
- Hubalek Z, Halouzka J. West Nile fever – a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis. 1999;5:643. doi: 10.3201/eid0505.990505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hubalek Z, Rudolf I, Bakonyi T, Kazdova K, Halouzka J, Sebesta O, Sikutova S, Juricova Z, Nowotny N. Mosquito (Diptera: Culicidae) surveillance for arboviruses in an area endemic for West Nile (Lineage Rabensburg) and Tahyna viruses in Central Europe. J Med Entomol. 2010;47:466–472. doi: 10.1603/me09219. [DOI] [PubMed] [Google Scholar]
- Jenkins GM, Rambaut A, Pybus OG, Holmes EC. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol. 2002;54:156–165. doi: 10.1007/s00239-001-0064-3. [DOI] [PubMed] [Google Scholar]
- Jerzak GV, Bernard K, Kramer LD, Shi PY, Ebel GD. The West Nile virus mutant spectrum is host-dependant and a determinant of mortality in mice. Virology. 2007;360:469–476. doi: 10.1016/j.virol.2006.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jerzak G, Bernard KA, Kramer LD, Ebel GD. Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol. 2005;86:2175–2183. doi: 10.1099/vir.0.81015-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jia XY, Briese T, Jordan I, Rambaut A, Chang Chi H, Mackenzie JS, Hall RA, Scherret J, Lipkin WI. Genetic analysis of West Nile New York 1999 encephalitis virus. The Lancet. 1999;354:1971–1972. doi: 10.1016/s0140-6736(99)05384-2. [DOI] [PubMed] [Google Scholar]
- Khromykh AA, Meka H, Guyatt KJ, Westaway EG. Essential role of cyclization sequences in flavivirus RNA replication. J Virol. 2001;75:6719–6728. doi: 10.1128/JVI.75.14.6719-6728.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kilpatrick AM, Meola MA, Moudy RM, Kramer LD. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog. 2008;4:e1000092. doi: 10.1371/journal.ppat.1000092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kilpatrick AM, Kramer LD, Campbell SR, Alleyne EO, Dobson AP, Daszak P. West Nile virus risk assessment and the bridge vector paradigm. Emerg Infect Dis. 2005;11:425–429. doi: 10.3201/eid1103.040364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kilpatrick AM, Kramer LD, Jones MJ, Marra PP, Daszak P. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol. 2006;4:e82. doi: 10.1371/journal.pbio.0040082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- King AMQ, Lefkowitz E, Adams MJ, Carstens EB. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. 1. Elsevier; San Diego, CA: 2011. [Google Scholar]
- Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, Davis B, Bowen R, Bunning M. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9:311. doi: 10.3201/eid0903.020628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kramer LD, Styer LM, Ebel GD. A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol. 2008;63:81. doi: 10.1146/annurev.ento.53.103106.093258. [DOI] [PubMed] [Google Scholar]
- Kramer LD, Bernard KA. West Nile virus infection in birds and mammals. Ann N Y Acad Sci. 2001;951:84–93. doi: 10.1111/j.1749-6632.2001.tb02687.x. [DOI] [PubMed] [Google Scholar]
- Kuno G, Chang GJJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus Flavivirus. J Virol. 1998;72:73–83. doi: 10.1128/jvi.72.1.73-83.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kutasi O, Bakonyi T, Lecollinet S, Biksi I, Ferenczi E, Bahuon C, Sardi S, Zientara S, Szenci O. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. J Vet Intern Med. 2011;25(3):586–591. doi: 10.1111/j.1939-1676.2011.0715.x. [DOI] [PubMed] [Google Scholar]
- Lanciotti R, Roehrig J, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe K, Crabtree M, Scherret J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999;286:2333. doi: 10.1126/science.286.5448.2333. [DOI] [PubMed] [Google Scholar]
- Langevin S, Bowen R, Ramey W, Sanders T, Maharaj P, Fang Y, Cornelius J, Barker C, Reisen W, Beasley D. Envelope and pre-membrane structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J Gen Virol. 2011;92(Pt 12):2810–2820. doi: 10.1099/vir.0.035535-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, Garcia-Sastre A, Khromykh AA, Best SM. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol. 2010;84:3503–3515. doi: 10.1128/JVI.01161-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li J, Bhuvanakantham R, Howe J, Ng ML. The glycosylation site in the envelope protein of West Nile virus (Sarafend) plays an important role in replication and maturation processes. J Gen Virol. 2006;87:613–622. doi: 10.1099/vir.0.81320-0. [DOI] [PubMed] [Google Scholar]
- Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol. 2006;80:2396–2404. doi: 10.1128/JVI.80.5.2396-2404.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, Khromykh AA. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol. 2005;79:1934–1942. doi: 10.1128/JVI.79.3.1934-1942.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lucas M, Mashimo T, Frenkiel MP, Simon-Chazottes D, Montagutelli X, Ceccaldi PE, Guénet JL, Desprès P. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase 1b protein. Immunol Cell Biol. 2003;81:230–236. doi: 10.1046/j.1440-1711.2003.01166.x. [DOI] [PubMed] [Google Scholar]
- May FJ, Davis CT, Tesh RB, Barrett ADT. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol. 2011;85:2964. doi: 10.1128/JVI.01963-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- May FJ, Li L, Davis CT, Galbraith SE, Barrett ADT. Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. Virology. 2010;405:8–14. doi: 10.1016/j.virol.2010.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLean R, Ubico S, Docherty D, Hansen W, Sileo L, McNamara T. West Nile virus transmission and ecology in birds. Ann N Y Acad Sci. 2001;951:54. doi: 10.1111/j.1749-6632.2001.tb02684.x. [DOI] [PubMed] [Google Scholar]
- McMullen AR, May FJ, Li L, Guzman H, Bueno R, Jr, Dennett JA, Tesh RB, Barrett ADT. Evolution of new genotype of West Nile virus in North America. Strain. 2011;17 doi: 10.3201/eid1705.101707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mertens E, Kajaste-Rudnitski A, Torres S, Funk A, Frenkiel MP, Iteman I, Khromykh AA, Despres P. Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. Virology. 2010;399:176–185. doi: 10.1016/j.virol.2009.12.036. [DOI] [PubMed] [Google Scholar]
- Molaei G, Cummings RF, Su T, Armstrong PM, Williams GA, Cheng ML, Webb JP, Andreadis TG. Vector–host interactions governing epidemiology of West Nile virus in Southern California. Am J Trop Med Hyg. 2010;83:1269. doi: 10.4269/ajtmh.2010.10-0392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Molaei G, Andreadis TG. Identification of avian-and mammalian-derived bloodmeals in Aedes vexans and Culiseta melanura (Diptera: Culicidae) and its Implication for West Nile Virus transmission in Connecticut, USA. J Med Entomol. 2006;43:1088–1093. doi: 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
- Monaco F, Savini G, Calistri P, Polci A, Pinoni C, Bruno R, Lelli R. 2009 West Nile disease epidemic in Italy: First evidence of overwintering in Western Europe? Res Vet Sci. 2011;91:321–326. doi: 10.1016/j.rvsc.2011.01.008. [DOI] [PubMed] [Google Scholar]
- Moudy RM, Meola MA, Morin LLL, Ebel GD, Kramer LD. A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg. 2007;77:365. [PubMed] [Google Scholar]
- Moudy RM, Zhang B, Shi PY, Kramer LD. West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology. 2009;387:222–228. doi: 10.1016/j.virol.2009.01.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. Structure of West Nile virus. Science. 2003;302:248. doi: 10.1126/science.1089316. [DOI] [PubMed] [Google Scholar]
- Muñoz-Jordán JL, Sanchez-Burgos GG, Laurent-Rolle M, García-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA. 2003;100:14333–14338. doi: 10.1073/pnas.2335168100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murata R, Eshita Y, Maeda A, Maeda J, Akita S, Tanaka T, Yoshii K, Kariwa H, Umemura T, Takashima I. Glycosylation of the West Nile virus envelope protein increases in vivo and in vitro viral multiplication in birds. Am J Trop Med Hyg. 2010;82:696. doi: 10.4269/ajtmh.2010.09-0262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murray KO, Mertens E, Desprès P. West Nile virus and its emergence in the United States of America. Vet Res. 2010a:41. doi: 10.1051/vetres/2010039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, Tesh RB, Fisher-Hoch S. Persistent infection with West Nile virus years after initial infection. J Infect Dis. 2010b;201:2–4. doi: 10.1086/648731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Papa A, Danis K, Baka A, Bakas A, Dougas G, Lytras T, Theocharopoulos G, Chrysagis D, Vassiliadou E, Kamaria F. Ongoing outbreak of West Nile virus infections in humans in Greece, July–August 2010. Age. 2010;20:20–29. doi: 10.2807/ese.15.34.19644-en. [DOI] [PubMed] [Google Scholar]
- Papa A, Xanthopoulou K, Gewehr S, Mourelatos S. Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin Microbiol Infect. 2011;17(8):1176–1180. doi: 10.1111/j.1469-0691.2010.03438.x. [DOI] [PubMed] [Google Scholar]
- Platonov AE. West Nile Encephalitis in Russia 1999–2001. Ann N Y Acad Sci. 2001;951:102–116. doi: 10.1111/j.1749-6632.2001.tb02689.x. [DOI] [PubMed] [Google Scholar]
- Rappole JH, Compton BW, Leimgruber P, Robertson J, King DI, Renner SC. Modeling movement of West Nile virus in the Western hemisphere. Vector Borne Zoonotic Dis. 2006;6:128–139. doi: 10.1089/vbz.2006.6.128. [DOI] [PubMed] [Google Scholar]
- Ronquist F, Huelsenbeck JP. MRBAYES 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003;19:1572–1574. doi: 10.1093/bioinformatics/btg180. [DOI] [PubMed] [Google Scholar]
- Samuel MA, Diamond MS. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80:9349. doi: 10.1128/JVI.01122-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schubert AM, Putonti C. Evolution of the sequence composition of Flaviviruses. Infect Genet Evol. 2010;10:129–136. doi: 10.1016/j.meegid.2009.11.004. [DOI] [PubMed] [Google Scholar]
- Shirato K, Miyoshi H, Goto A, Ako Y, Ueki T, Kariwa H, Takashima I. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol. 2004;85:3637. doi: 10.1099/vir.0.80247-0. [DOI] [PubMed] [Google Scholar]
- Smith DR, Adams AP, Kenney JL, Wang E, Weaver SC. Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: Infection initiated by a small number of susceptible epithelial cells and a population bottleneck. Virology. 2008;372:176–186. doi: 10.1016/j.virol.2007.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smithburn K, Hughes T, Burke A, Paul J. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg. 1940;20:471–473. [Google Scholar]
- Snapinn KW, Holmes EC, Young DS, Bernard KA, Kramer LD, Ebel GD. Declining growth rate of West Nile virus in North America. J Virol. 2007;81:2531. doi: 10.1128/JVI.02169-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsai T, Popovici F, Cernescu C, Campbell G, Nedelcu N. West Nile encephalitis epidemic in southeastern Romania. The Lancet. 1998;352:767–771. doi: 10.1016/s0140-6736(98)03538-7. [DOI] [PubMed] [Google Scholar]
- Tsai TF, Mitchell CJ, Monath TP. St. Louis encephalitis In: , editor. The Arboviruses: Epidemiology and Ecology. CRC; Boca Raton, FL: 1989. pp. 113–143. [Google Scholar]
- Tuplin A, Evans D, Buckley A, Jones I, Gould E, Gritsun T. Replication enhancer elements within the open reading frame of tick-borne encephalitis virus and their evolution within the Flavivirus genus. Nucleic Acids Res. 2011;39(16):7034–7048. doi: 10.1093/nar/gkr237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turell MJ, Dohm DJ, Sardelis MR, Oguinn ML, Andreadis TG, Blow JA. An update on the potential of North American mosquitoes (Diptera: Culicidae) to transmit West Nile virus. J Med Entomol. 2005;42:57–62. doi: 10.1093/jmedent/42.1.57. [DOI] [PubMed] [Google Scholar]
- Turell MJ, Sardelis MR, O’Guinn ML, Dohm DJ. Potential vectors of West Nile virus in North America. Curr Top Microbiol Immunol. 2002;267:241–252. doi: 10.1007/978-3-642-59403-8_12. [DOI] [PubMed] [Google Scholar]
- Vazquez A, Sanchez-Seco MP, Ruiz S, Molero F, Hernandez L, Moreno J, Magallanes A, Tejedor CG, Tenorio A. Putative new lineage of west nile virus. Spain Emerg Infect Dis. 2010;16:549–552. doi: 10.3201/eid1603.091033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venkatesan M, Rasgon JL. Population genetic data suggest a role for mosquito-mediated dispersal of West Nile virus across the western United States. Mol Ecol. 2010;19:1573–1584. doi: 10.1111/j.1365-294X.2010.04577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venter M, Human S, Zaayman D, Gerdes GH, Williams J, Steyl J, Leman PA, Paweska JT, Setzkorn H, Rous G. Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis. 2009;15:877. doi: 10.3201/eid1506.081515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venter M, Swanepoel R. West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis. 2010;10:659–664. doi: 10.1089/vbz.2009.0230. [DOI] [PubMed] [Google Scholar]
- Vitek CJ, Richards SL, Mores CN, Day JF, Lord CC. Arbovirus transmission by Culex nigripalpus in Florida, 2005. J Med Entomol. 2008;45:483. doi: 10.1603/0022-2585(2008)45[483:atbcni]2.0.co;2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weaver SC. Evolutionary influences in arboviral disease. Curr Top Microbiol Immunol. 2006;299:285–314. doi: 10.1007/3-540-26397-7_10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westaway EG, Mackenzie JM, Khromykh AA. Replication and gene function in Kunjin virus. Curr Top Microbiol Immunol. 2002;267:323–351. doi: 10.1007/978-3-642-59403-8_16. [DOI] [PubMed] [Google Scholar]
- Wicker JA, Whiteman MC, Beasley DWC, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett ADT. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology. 2006;349:245–253. doi: 10.1016/j.virol.2006.03.007. [DOI] [PubMed] [Google Scholar]
- Wilson JR, de Sessions PF, Leon MA, Scholle F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol. 2008;82:8262–8271. doi: 10.1128/JVI.00226-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoon SW, Lee SY, Won SY, Park SH, Park SY, Jeong YS. Characterization of homologous defective interfering RNA during persistent infection of Vero cells with Japanese encephalitis virus. Mol Cells. 2006;21:112–120. [PubMed] [Google Scholar]
- Zehender G, Ebranati E, Bernini F, Presti AL, Rezza G, Delogu M, Galli M, Ciccozzi M. Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect Genet Evol. 2011;11(5):863–868. doi: 10.1016/j.meegid.2011.02.003. [DOI] [PubMed] [Google Scholar]
- Zeller H, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis. 2004;23:147–156. doi: 10.1007/s10096-003-1085-1. [DOI] [PubMed] [Google Scholar]
- Zhang B, Dong H, Stein DA, Iversen PL, Shi PY. West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions. Virology. 2008;373:1–13. doi: 10.1016/j.virol.2008.01.016. [DOI] [PubMed] [Google Scholar]
- Zou G, Puig-Basagoiti F, Zhang B, Qing M, Chen L, Pankiewicz KW, Felczak K, Yuan Z, Shi PY. A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology. 2009a;384:242–252. doi: 10.1016/j.virol.2008.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zou G, Zhang B, Lim PY, Yuan Z, Bernard KA, Shi PY. Exclusion of West Nile virus superinfection through RNA replication. J Virol. 2009b;83:11765–11776. doi: 10.1128/JVI.01205-09. [DOI] [PMC free article] [PubMed] [Google Scholar]